Pharmacological preconditioning with resveratrol: role of nitric oxide.
about
Effects of some common food constituents on cardiovascular diseaseNitric Oxide as a Unique Bioactive Signaling Messenger in Physiology and Pathophysiology.Targeting Nitric Oxide with Natural Derived Compounds as a Therapeutic Strategy in Vascular DiseasesRestoration of altered microRNA expression in the ischemic heart with resveratrolResveratrol protects C6 astrocyte cell line against hydrogen peroxide-induced oxidative stress through heme oxygenase 1Redox regulation of ischemic preconditioning is mediated by the differential activation of caveolins and their association with eNOS and GLUT-4Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol.Mechanism for resveratrol-induced cardioprotection against reperfusion injury involves glycogen synthase kinase 3beta and mitochondrial permeability transition pore.Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection.Dose-dependency of resveratrol in providing health benefits.Activation of mitochondrial energy metabolism protects against cardiac failure.Red wine: A drink to your heart.Cellular and mitochondrial effects of alcohol consumption.Experimental evidence for the cardioprotective effects of red wine.Resveratrol addiction: to die or not to die.Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease.Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium.Inhibition of Na⁺-H⁺ exchange as a mechanism of rapid cardioprotection by resveratrol.Resveratrol: a medical drug for acute pancreatitis.Vascular dysfunction in aging: potential effects of resveratrol, an anti-inflammatory phytoestrogen.Significance of wine and resveratrol in cardiovascular disease: French paradox revisitedEthanol for cardiac ischemia: the role of protein kinase c.Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase.Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and γ-tocotrienol.Sulindac confers high level ischemic protection to the heart through late preconditioning mechanisms.Resveratrol: a promising agent in promoting cardioprotection against coronary heart disease.Is the use of resveratrol in the treatment and prevention of obesity premature?Exercise preconditioning of the myocardium.Resveratrol and red wine, healthy heart and longevity.Anti-atherogenic effects of resveratrol.Physiological effects of resveratrol.Effects of resveratrol and flavonols on cardiovascular function: Physiological mechanisms.Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease.Erratum to: resveratrol and red wine, healthy heart and longevity.Resveratrol in cardiovascular disease: what is known from current research?Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.Natural polyphenols and spinal cord injury
P2860
Q24605384-5F702316-CB1C-46FC-BA7C-331DFABBB61DQ24805828-FA95D8B4-B5CE-4674-82B1-446B858CA6DFQ28073279-BBDF37BA-ABAC-426B-99E4-8124237F7238Q28476630-32333BB7-AF16-4E28-BDAE-7F29C745ED55Q28488046-49346C26-1B69-42BB-9E0A-5F79A8874ECDQ28580853-4ED4E137-36E7-4F35-AA10-423DAC51956CQ33264601-2C8E40E4-3693-4FCD-BE20-172E53D752C0Q33818343-6B9B7864-31A1-455F-BE8B-BE47F67C93A5Q34166155-38002856-6CC7-4AFD-8071-B53CD4541DFAQ34341938-1AFE5C3B-7AE1-4E3A-87A9-61A86FAE5F84Q34424919-45D264D9-4F7D-42DA-844F-73C74315AA94Q34504802-D8F990B6-C798-4060-B689-41BED93DB897Q34566111-42E1D8D5-D6AB-4EA5-9BFC-174F072E1120Q34594669-714823B5-EDA1-400E-92A9-A8731B3161C8Q34601716-D8B309A0-EEBF-42D1-91FF-46A164233804Q35058257-DA5B1DAC-6C65-40A4-BD93-E6D979B779BFQ35886665-825D5152-5419-4C76-9E99-D37F95D7F8D0Q36110568-9FC599CC-8B1F-498E-9268-880BBA24950BQ36147106-9FD9C071-B6BA-4CE9-8864-CA2B620827C6Q36431841-BF19BF68-E505-40F7-8037-1B46A4B5E06CQ36511645-9631D90A-2467-4EE0-BEC7-55EBF6A22531Q36694026-44BA4194-56EF-4CCF-B0EF-0312EA054C26Q36980730-0FAD1831-5A0E-422F-8F6A-E98049185272Q37014196-03C5EAA7-211F-4556-A3C0-0FB50DB540D7Q37038768-F83476DC-0EDD-406B-AD5F-A64DA11457D4Q37296261-2EA718A1-B140-4E4D-AE05-4DA9503D61FDQ37429016-57341269-97DF-4B5D-A0D5-A2029FB793EEQ37445518-063CD883-9A4C-4F0D-8F33-D3D622B81D04Q37601527-EEBC6808-9C3F-4D54-B3A2-B60AC2A0C77BQ37614509-BDF1B48A-410A-472B-855B-C7BE832B19BEQ37711262-51960828-A7D4-4E57-B5A3-6595EDD407DAQ37756520-32CECFC1-2E32-4B5B-B5FA-6C9D4E571605Q37771916-AF234B9B-DC35-4CA6-B28B-B50E4896B5C7Q37783970-0DC866AA-B736-4ED4-8FC1-1CB24B484357Q37831940-4BB7DA7A-62AA-47B1-B89A-EC2BF0C429F7Q37852611-4F8F35E8-189F-4D8F-84AA-0DA0DED09D29Q37891880-C480D0A4-284C-4BF6-B947-74DE075A81BEQ37995917-27FA6CD8-55E6-4AD9-A1B2-1130B032E723Q38061499-80043A52-2FCC-4205-99BC-FFE9A9742339Q38212924-0E958E81-09AE-4EDE-9C38-AA58AA32E5D0
P2860
Pharmacological preconditioning with resveratrol: role of nitric oxide.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@en
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@nl
type
label
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@en
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@nl
prefLabel
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@en
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@nl
P2093
P2860
P1476
Pharmacological preconditioning with resveratrol: role of nitric oxide.
@en
P2093
Dipak K Das
Hajime Otani
Nilanjana Maulik
Reiji Hattori
P2860
P304
P356
10.1152/AJPHEART.01012.2001
P577
2002-06-01T00:00:00Z